2.05% -0.04

Sellas Life Sciences Group Inc (SLS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SLS Giù? Forum Previsione Frazionamento azionario

Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Selling, General, and Administrative	5.04% 3.002	2.858	2.481	2.967	2.435
Costs And Expenses	13.36% 6.873	6.063	6.918	7.329	7.621
Operating Income/Loss	13.36% -6.873	-6.063	-6.918	-7.329	-7.621
Nonoperating Income/Loss	8.80% 0.272	0.25	0.181	0.221	0.151
Income/Loss From Continuing Operations Before Tax	13.36% -6.873	-6.063	-6.286	-7.329	-7.621
Income/Loss From Continuing Operations After Tax	13.56% -6.601	-5.813	-6.737	-7.108	-7.47
Net Income/Loss	13.56% -6.601	-5.813	-6.737	-7.108	-7.47
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	12.30% 98.56	87.76	4.2618	68.25	57.63
Diluted Average Shares	12.30% 98.56	87.76	4.2618	68.25	57.63
Basic Earnings Per Share	0.00% -0.07	-0.07	-0.08	-0.10	-0.13
Diluted Earnings Per Share	0.00% -0.07	-0.07	-0.08	-0.10	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.40

0.12%

GMAB

$28.93

0.31%

INCY

$100.87

0.65%

BNTX

$104.19

0.09%

ONC

$310.10

0.62%

INSM

$186.49

0.07%